Biotech · Private company
Glenmark Specialty S.A.
Track this companyFree. Adds Glenmark Specialty S.A. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- GSP 301 NSPhase 3 · Perennial Allergic RhinitisClinicalTrials.gov · fetched Nov 12, 2026
- GSP 301 NSPhase 3 · Seasonal Allergic Rhinitis (SAR)ClinicalTrials.gov · fetched Nov 12, 2026
- GSP304 (tiotropium bromide) Inhalation SolutionPhase 2 · Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)ClinicalTrials.gov · fetched Nov 12, 2026
- Spiriva® Respimat® inhalation sprayPhase 2 · Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)ClinicalTrials.gov · fetched Nov 12, 2026
- GRC 54276Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- GRC 54276 + AtezolizumabPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- GRC 54276 + PembrolizumabPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.PHASE1 · ACTIVE_NOT_RECRUITING · started Jun 28, 2022ClinicalTrials.gov NCT05878691 · fetched Nov 12, 2026
- Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)PHASE3 · COMPLETED · started Mar 16, 2018ClinicalTrials.gov NCT03463031 · fetched Nov 12, 2026
- Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)PHASE2 · COMPLETED · started Mar 24, 2017ClinicalTrials.gov NCT03118765 · fetched Nov 12, 2026
- Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)PHASE3 · COMPLETED · started Apr 1, 2016ClinicalTrials.gov NCT02709538 · fetched Nov 12, 2026